Synonym
BCX 2600; BCX-2600; BCX2600; Diacomit; Estiripentol;
IUPAC/Chemical Name
1-(1,3-Benzodioxol-5-yl)-4,4-dimethyl-1-penten-3-ol
InChi Key
IBLNKMRFIPWSOY-FNORWQNLSA-N
InChi Code
InChI=1S/C14H18O3/c1-14(2,3)13(15)7-5-10-4-6-11-12(8-10)17-9-16-11/h4-8,13,15H,9H2,1-3H3/b7-5+
SMILES Code
CC(C)(C)C(O)/C=C/C1=CC=C(OCO2)C2=C1
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
234.30
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Available from http://www.ncbi.nlm.nih.gov/books/NBK548951/ PubMed PMID: 31644256.
2: Frampton JE. Stiripentol: A Review in Dravet Syndrome. Drugs. 2019 Nov;79(16):1785-1796. doi: 10.1007/s40265-019-01204-y. Review. PubMed PMID: 31617141.
3: Eschbach K, Knupp KG. Stiripentol for the treatment of seizures in Dravet syndrome. Expert Rev Clin Pharmacol. 2019 May;12(5):379-388. doi: 10.1080/17512433.2019.1605904. Epub 2019 Apr 24. Review. PubMed PMID: 31017478.
4: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK535603/ PubMed PMID: 30601612.
5: Brigo F, Igwe SC, Bragazzi NL. Stiripentol add-on therapy for focal refractory epilepsy. Cochrane Database Syst Rev. 2018 May 10;5:CD009887. doi: 10.1002/14651858.CD009887.pub4. Review. PubMed PMID: 29747241; PubMed Central PMCID: PMC6494649.
6: Nickels KC, Wirrell EC. Stiripentol in the Management of Epilepsy. CNS Drugs. 2017 May;31(5):405-416. doi: 10.1007/s40263-017-0432-1. Review. PubMed PMID: 28434133.
7: Stiripentol (Diacomit): For Severe Myoclonic Epilepsy in Infancy (Dravet Syndrome) [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Apr. Available from http://www.ncbi.nlm.nih.gov/books/NBK349342/ PubMed PMID: 26962599.
8: Chiron C. Stiripentol and vigabatrin current roles in the treatment of epilepsy. Expert Opin Pharmacother. 2016 Jun;17(8):1091-101. doi: 10.1517/14656566.2016.1161026. Epub 2016 Mar 17. Review. PubMed PMID: 26933940.
9: Verrotti A, Prezioso G, Stagi S, Paolino MC, Parisi P. Pharmacological considerations in the use of stiripentol for the treatment of epilepsy. Expert Opin Drug Metab Toxicol. 2016;12(3):345-52. doi: 10.1517/17425255.2016.1145657. Epub 2016 Feb 18. Review. PubMed PMID: 26890312.
10: Brigo F, Storti M, Igwe SC. Stiripentol for focal refractory epilepsy. Cochrane Database Syst Rev. 2015 Oct 21;(10):CD009887. doi: 10.1002/14651858.CD009887.pub3. Review. Update in: Cochrane Database Syst Rev. 2018 May 10;5:CD009887. PubMed PMID: 26488459.
11: Brigo F, Storti M. Stiripentol for focal refractory epilepsy. Cochrane Database Syst Rev. 2014 Jan 31;(1):CD009887. doi: 10.1002/14651858.CD009887.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;(10):CD009887. PubMed PMID: 24488598.
12: Plosker GL. Stiripentol : in severe myoclonic epilepsy of infancy (dravet syndrome). CNS Drugs. 2012 Nov;26(11):993-1001. doi: 10.1007/s40263-012-0004-3. Review. PubMed PMID: 23018548.
13: Verdier MC, Tribut O, Bentué-Ferrer D. [Therapeutic drug monitoring of stiripentol]. Therapie. 2012 Mar-Apr;67(2):157-60. doi: 10.2515/therapie/2012014. Epub 2012 Aug 2. Review. French. PubMed PMID: 22850103.
14: Nabbout R, Chiron C. Stiripentol: an example of antiepileptic drug development in childhood epilepsies. Eur J Paediatr Neurol. 2012 Sep;16 Suppl 1:S13-7. doi: 10.1016/j.ejpn.2012.04.009. Epub 2012 Jun 12. Review. PubMed PMID: 22695038.
15: Fisher JL. The effects of stiripentol on GABA(A) receptors. Epilepsia. 2011 Apr;52 Suppl 2:76-8. doi: 10.1111/j.1528-1167.2011.03008.x. Review. PubMed PMID: 21463286; PubMed Central PMCID: PMC3652007.
16: Chiron C. Stiripentol. Neurotherapeutics. 2007 Jan;4(1):123-5. Review. PubMed PMID: 17199026.
17: Chiron C. Stiripentol. Expert Opin Investig Drugs. 2005 Jul;14(7):905-11. Review. PubMed PMID: 16022579.
18: Trojnar MK, Wojtal K, Trojnar MP, Czuczwar SJ. Stiripentol. A novel antiepileptic drug. Pharmacol Rep. 2005 Mar-Apr;57(2):154-60. Review. PubMed PMID: 15886413.
19: Stiripentol. BCX 2600. Drugs R D. 2002;3(3):220-2. Review. PubMed PMID: 12099174.
20: Bebin M, Bleck TP. New anticonvulsant drugs. Focus on flunarizine, fosphenytoin, midazolam and stiripentol. Drugs. 1994 Aug;48(2):153-71. Review. PubMed PMID: 7527321.
